NCT06352411View on ClinicalTrials.gov

A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

September 16, 2025

Study Completion Date

September 23, 2025

Conditions
HealthyRenal Impairment
Interventions
DRUG

BI 456906

Solution for injection

Trial Locations (2)

24105

CRS Clinical Research Services Kiel GmbH, Kiel

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06352411 - A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems | Biotech Hunter | Biotech Hunter